Rapid, targeted eradication of anaerobic bacterial and protozoal infections: Metrogyl 200 mg begins exerting antimicrobial activity within one to two hours of oral administration, with clinical improvement in infection symptoms typically observable within a few days of commencing a full treatment course. Its precise intracellular DNA-disruption mechanism targets and eliminates susceptible organisms at the source without the broad-spectrum collateral disruption of aerobic gut flora that characterises many other antibiotic classes.

Outstanding tissue penetration for deep-seated infections: Metronidazole's physicochemical properties allow it to distribute extensively across body compartments, including the cerebrospinal fluid, hepatic parenchyma, bile, abscessed cavities, and inflamed intestinal mucosa, reaching therapeutic concentrations at sites that are often inaccessible to less lipophilic antibiotics. This depth of tissue penetration makes it the preferred choice of veterinarians for infections that extend beyond the intestinal lumen, including hepatic amoebiasis and anaerobic soft tissue infections.

Dual antiprotozoal and antibacterial activity in a single oral formulation: Unlike antibiotics that target only bacteria or only protozoa, metronidazole's mechanism of action is effective against both classes of pathogen, allowing veterinarians to use a single agent for mixed gastrointestinal infections involving both anaerobic bacteria and protozoal organisms. This dual efficacy reduces polypharmacy in complex gastrointestinal cases and simplifies administration for pet parents managing multiday treatment courses.

Relieves acute gastrointestinal distress associated with giardiasis and colitis: By directly targeting the protozoal trophozoites and anaerobic bacteria responsible for causing intestinal inflammation, diarrhoea, mucoid stools, and abdominal discomfort, Metrogyl 200 mg alleviates the clinical signs of gastrointestinal infection progressively as the causative organisms are eliminated. This anti-infective activity is complemented by metronidazole's additional anti-inflammatory and immunomodulatory properties within intestinal mucosa, contributing to restoration of normal gut function.

Established clinical record and trusted manufacture by a WHO-GMP-certified facility: Metrogyl has been one of JB Pharma's flagship brands for decades and is among the top 300 prescription brands in the Indian pharmaceutical market, reflecting its long-standing clinical acceptance across both human and veterinary medicine. Each tablet is produced to the highest quality standards at JB Pharma's Gujarat manufacturing facilities, which hold over 40 global accreditations including US-FDA, EU-GMP, WHO-GMP, and ISO 9001:2015 certifications.

How to Use:

Metrogyl 200 mg Tablet must be administered only under the prescription and direction of a licensed veterinarian, who will determine the correct dose, frequency, and duration of treatment based on your pet's species, body weight, specific infection, clinical condition, and any concurrent medications. This is a prescription-only medicine and must not be administered without veterinary authorisation. The veterinarian-prescribed dose should be given orally, ideally with or immediately after food to reduce the risk of gastric irritation and to support absorption. For dogs and cats, the tablet should be administered whole where possible; if your pet is reluctant to swallow tablets, your veterinarian may advise a palatable hiding strategy or discuss a compounded liquid formulation. Never crush Metrogyl tablets and mix them loosely into food without veterinary guidance, as metronidazole has an intensely bitter taste that may cause strong aversion in cats and some dogs. Administer each dose at the same time each day to maintain consistent blood levels throughout the treatment course. It is critically important to complete the full prescribed course of Metrogyl 200 mg, even if your pet's symptoms resolve before the course is finished; premature discontinuation may result in treatment failure, recurrence of infection, or the development of antimicrobial resistance. If a dose is accidentally missed, administer it as soon as possible, but do not double up doses. Avoid giving this medication to animals that are also receiving alcohol-containing liquid preparations, as a disulfiram-like reaction involving nausea, vomiting, and cardiovascular effects may occur.

Storage Advice:

Store unopened Metrogyl 200 mg Tablets in a cool, dry place below 25 degrees Celsius, away from direct sunlight and moisture. Do not freeze. Keep the tablets in their original blister pack until the time of administration to protect them from humidity and light degradation. Once a blister has been opened, use the tablet promptly. Do not use after the expiry date printed on the blister strip and outer carton. Keep this medication securely out of the reach of children and animals. Unused or expired tablets must be disposed of responsibly in accordance with local pharmaceutical waste disposal guidelines and must not be flushed down the drain or discarded in general household waste.

About the Brand:

J.B. Chemicals and Pharmaceuticals Ltd. (JB Pharma) was established in 1976 in India by the late Mr. J.B. Mody, building from foundational principles of ethics, integrity, and patient-centric pharmaceutical access that continue to define the company's identity nearly five decades later. Today operating as one of India's fastest-growing pharmaceutical companies, JB Pharma's seven state-of-the-art manufacturing units in Gujarat, India, hold over 40 global regulatory accreditations including US-FDA, EU-GMP, WHO-GMP, South Africa SAHPRA, and ISO 9001:2015 certifications, enabling the company to export a diverse range of formulations to over 40 regulated and semi-regulated markets worldwide. Metrogyl is one of JB Pharma's most storied and enduring flagship brands, ranking among the top 300 prescription medicines in India, and is trusted by healthcare and veterinary professionals across the country as a consistent, high-quality antiprotozoal and antibacterial formulation. The company's unwavering commitment to quality, regulatory compliance, and affordable pharmaceutical access aligns with Animeal's commitment to providing only the safest and most clinically credible prescription veterinary medicines to Indian pet parents. Discover the full JB Pharma range today through Animeal.

Disclaimer:

Please note that while Metrogyl 200 mg Tablet is formulated from metronidazole, a well-established nitroimidazole antibiotic and antiprotozoal agent, and is used under veterinary prescription for the management of anaerobic bacterial and protozoal infections in companion animals, it is a prescription-only pharmaceutical medicine and must not be purchased, dispensed, or administered without a valid prescription issued by a licensed veterinarian. This product is a human-labelled pharmaceutical used off-label in veterinary species and must only be administered to companion animals at doses, frequencies, and durations specifically directed by your veterinarian, as inappropriate dosing may result in neurological toxicity, particularly in dogs at high doses. Metrogyl 200 mg is not a complete treatment for all gastrointestinal conditions and does not replace a comprehensive veterinary diagnosis, laboratory confirmation of the causative organism, or an individualised treatment plan. For pets with known hypersensitivity to metronidazole or other nitroimidazoles, pre-existing liver disease, neurological conditions, blood disorders, or concurrent medications including anticoagulants, consult your veterinarian before initiating treatment. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.